Clinical Trials Directory

Trials / Completed

CompletedNCT00574158

Pathogenesis and Genetics of Environmental Asthma Ozone Study

Project 2: Genetic Regulation of Ozone Induced Inflammation in Humans.

Status
Completed
Phase
Study type
Observational
Enrollment
170 (actual)
Sponsor
National Institute of Environmental Health Sciences (NIEHS) · NIH
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The goals of the research are designed to accomplish genetic association studies of candidate genes in healthy normal individuals exposed to 0.2 ppm for 2.25 hours with intermittent exercise in order to search for associations between defined genotypes/haplotypes and 3 specific in vivo respiratory endpoints: a) change in FEV1 immediately after ozone exposure; b) change nonspecific bronchial reactivity as reflected in the change in methacholine PC20 FEV1 24 hours after ozone exposure ; and c) change in lung epithelial integrity as reflected in the Clearance Halftime of technetium 24 hours after ozone exposure. These studies have been carried forward to take place in 4 phases: i) healthy individuals have been exposed to O3 using our standard exposure protocol; and we will increase the numbers of individuals available for study. ii) perform genetic association studies for the endpoints of spirometry (FEV1, FVC, FEV1/FVC), PC20 FEV1 for methacholine, and epithelial integrity (Clearance Halftime) for 3 candidate O3 response genes taken from literature searches and/or previously characterized to demonstrate associations. These physiologic endpoints have been examined in terms of both a continuum of response, and discrete "responder" and "non-responder" endpoints.

Conditions

Timeline

Start date
2005-07-01
Primary completion
2011-11-01
Completion
2012-06-01
First posted
2007-12-17
Last updated
2014-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00574158. Inclusion in this directory is not an endorsement.